| Literature DB >> 35274822 |
María Auxiliadora Robles-Bello1, David Sánchez-Teruel2, Nieves Valencia Naranjo1, Lorabi Sohaib1.
Abstract
BACKGROUND: Drastic changes in the lifestyle of individuals have been caused by coronarivus SARS-CoV-2 with lethal effects associated with COVID-19, which acts as a stressor for the population with adverse effects on mental health status. The aim was to identify which sociodemographic variables and psychological factors predict psychological disorders in the general Spanish population.Entities:
Keywords: COVID-19; hope; mental health; pandemic; self-efficacy
Mesh:
Year: 2022 PMID: 35274822 PMCID: PMC9014993 DOI: 10.1002/brb3.2515
Source DB: PubMed Journal: Brain Behav Impact factor: 3.405
Description of sociodemographic data of the simple
|
| Women, | Men, | |
|---|---|---|---|
| Age | |||
| 18–28 | 426 (60.94) | 247 (57.98) | 179 (42.02) |
| 29–39 | 132 (18.89) | 79 (59.85) | 53 (40.15) |
| 40–49 | 124 (17.74) | 66 (53.23) | 58 (46.77) |
| Over 50 | 17 (2.43) | 10 (58.82) | 7 (41.18) |
| Do you work or study? | |||
| Study | 255 (36.48) | 149 (58.43) | 106 (41.57) |
| Work | 359 (51.36) | 203 (56.55) | 156 (43.45) |
| Study and work | 49 (7.01) | 29 (59.18) | 20 (40.82) |
| Retired | 14 (2.00) | 9 (64.29) | 5 (35.71) |
| Nothing | 22 (3.15) | 12 (54.55) | 10 (45.45) |
| Number of people confined in the same place | |||
| 1 | 38 (5.44) | 21(52.26) | 17(47.74) |
| 2 | 120 (17.17) | 75(62.50) | 45(37.50) |
| 3 | 167 (23.89) | 102 (61.08) | 65(38.92) |
| 4 | 279 (39.91) | 148 (53.05) | 131 (46.95) |
| 5 | 75 (10.73) | 45 (60.00) | 30 (40.00) |
| Over 6 | 20 (2.86) | 11 (55.00) | 9 (45.00) |
| Families with children under 14 | |||
| Yes | 152 (21.75) | 89 (58.55) | 63 (41.45) |
| No | 547 (78.25) | 313 (57.22) | 234 (42.78) |
| Families with people over 60 | |||
| Yes | 121 (17.31) | 78 (64.46) | 43 (35.54) |
| No | 578 (82.69) | 324 (56.06) | 254(43.94) |
| Presence of COVID‐19 infection | |||
| Yes | 19 (2.02) | 11 (57.89) | 8 (42.11) |
| No | 680 (97.28) | 391 (57.50) | 289 (42.50) |
| Relationship with essential service workers | |||
| Yes | 414 (59.23) | 238 (57.49) | 176 (42.51) |
| No | 285 (40.77) | 164 (57.54) | 121 (42.46) |
| Total | 699 (100) | 402 (100) | 297 (100) |
Frequency and percentages according to symptomatology group and sex
| HADA | HADD | ||||||
|---|---|---|---|---|---|---|---|
| Group/sex |
| % | FG/% |
| % | FG/% | |
| G0 | M | 111 | 15.88 | 324/46.41 | 154 | 22.03 | 519/74.3 |
| W | 213 | 30.47 | 365 | 52.21 | |||
| G1 | M | 50 | 7.15 | 181/25.89 | 19 | 2.72 | 96/13.75 |
| W | 131 | 18.74 | 77 | 11.02 | |||
| G2 | M | 23 | 3.29 | 129/18.45 | 17 | 2.43 | 66/9.45 |
| W | 106 | 15.16 | 49 | 7.01 | |||
| G3 | M | 10 | 1.43 | 65/9.30 | 4 | 0.57 | 18/2.57 |
| W | 55 | 7.87 | 14 | 2 | |||
F, frequency; FG, frequency per group; Group 0, no alteration; Group 1, mild symptomatology; Group 2, moderate symptomatology; Group 3, severe symptomatology HADA, Hospital Anxiety and Depression Scale (HAD) subscale; HADD, Hospital Anxiety and Depression Scale (HAD) subscale; M, man; W, woman; %, percentage.
Values of the stepwise regression equation for the prediction of measured symptomatology through the total anxiety and depression scale
| IC (95%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
| SE |
|
| L.I. | L.S. | ||
| Model 1 | .276 | 266.597** | |||||||
| HHI | −.613 | .038 | 16.328** | −.526 | −.687 | −.539 | |||
| Model 2 | .296 | 147.415** | |||||||
| Sex | 2.375 | .522 | 4.549** | .145 | 1.350 | 3.400 | |||
| HHI | −.602 | .037 | 16.245** | −.517 | −.675 | −.530 | |||
| Model 3 | .308 | 103.049** | |||||||
| Sex | 2.267 | .520 | 4.372** | .130 | 1.246 | 3.287 | |||
| HHI | −.510 | .047 | 10.940** | −.438 | −.602 | −.419 | |||
| GSE | −.178 | .055 | 3.217** | −.129 | −.286 | −.069 | |||
| Model 4 HAD | .312 | 79.949** | |||||||
| Sex | 2.358 | .518 | 4.550** | .144 | 1.341 | 3.376 | |||
| ConCov | 3.971 | 1.453 | 2.771* | .088 | 1.157 | 6.785 | |||
| GSE | −.174 | .055 | 3.154* | −.126 | −.282 | −.066 | |||
| HHI | −.499 | .047 | 20.707** | −.429 | −.591 | −.408 | |||
| Model 5 HADA | .209 | 46.972 | |||||||
| Sex | 1.433 | .321 | 4.465** | .151 | .803 | 2.064 | |||
| ConSer | .677 | .292 | 2.320* | .078 | .104 | 1.250 | |||
| HHI | −.209 | .029 | 7.261** | −.311 | −.266 | −.153 | |||
| GSE | −.120 | .034 | 3.514* | −.187 | −.187 | −.053 | |||
| Model 6 HADD | .320 | 110.248** | |||||||
| Sex | .932 | .274 | 3.398** | .107 | .394 | 1.470 | |||
| ConCov | 3.376 | .760 | 4.444** | .140 | 1.884 | 4.868 | |||
| HHI | −.322 | .020 | 16.393** | −.518 | −.360 | −.283 | |||
B, non‐standardized coefficient; β, result of the regression or beta equation; C.I., confidence intervals; ConCov, living with COVID‐19 sick persons; ConSer, living with essential service persons; F, contrast statistics (ANOVA); ns, not significant; g.l., degrees of freedom; GSE, general self‐efficacy; HHI, hope; L.I., lower limit; SE, standard error; S.L. ,upper limit; R 2, corrected determination coefficient; t, predictive variable contrast statistics.
*p < 0.05;**p < 0.01.